🌅 Today's Morning Call
|
S&P Futures
7,142.00
▲ +5.25 (+0.07%)
|
Nasdaq Futures
26,832.75
▲ +21.00 (+0.08%)
|
Dow Futures
49,638.00
▲ +82.00 (+0.17%)
|
|
10Y Treasury
4.29%
▲ +0.04%
|
US Dollar
98.44
▲ +0.04 (+0.04%)
|
Bitcoin
$78,342
▲ +$1,986 (+2.60%)
|
Data as of 8:08 AM ET
Good morning! Futures are pointing to a modestly higher open this Wednesday as earnings season rolls on and dealmaking activity picks up steam. Boeing is showing signs of life after quarters of turbulence, Merck is writing big checks in both tech and biotech, and oil prices just dipped back below $100 despite fresh tensions in the Strait of Hormuz. Here's what's moving markets before the bell.
👀 What to Watch Today
The big story today is whether Boeing's momentum can hold up under scrutiny. The aerospace giant (BA) posted narrower losses in Q1 thanks to higher aircraft deliveries and improved performance in its defense and services divisions. The 737 Max production line is humming again, and management is teasing new certifications later this year. Wall Street will be parsing the details to see if this recovery has legs or if it's just another false start.Merck (MRK) is playing offense on two fronts. The pharma heavyweight just announced a partnership with Google Cloud (GOOG, GOOGL) worth up to $1 billion to supercharge its AI capabilities, betting that machine learning can accelerate drug discovery. At the same time, Merck is reportedly circling Inhibrx Biosciences (INBX) alongside Germany's Merck KGaA and Japan's Ono Pharmaceutical in a bidding war for a cancer drug that could pair with Keytruda. The prize could fetch north of $8 billion.
Elsewhere, Palantir (PLTR) just locked down a $300 million contract with the USDA to provide software for managing farmland and protecting the food supply. It's another example of the data analytics firm expanding its government footprint beyond defense into agriculture and critical infrastructure.
🌏 Overnight Recap
Asian markets closed mixed overnight as traders digested the latest signals from central banks and monitored developments in the Middle East. Tokyo's Nikkei edged higher on tech strength, while Hong Kong's Hang Seng slipped on renewed property sector concerns. Chinese manufacturing data came in slightly below expectations, adding to questions about the pace of recovery in the world's second-largest economy.European bourses are trading in positive territory this morning, with the Stoxx 600 up modestly. Energy stocks are getting a lift despite oil pulling back from $100, and industrial names are bouncing on Boeing's improved outlook. The euro is holding steady against the dollar as ECB officials continue to signal patience on rate cuts.
Oil markets are the headline act overnight. Brent crude spiked after two ships were reportedly struck in the Strait of Hormuz, but prices quickly retreated below $100 after President Trump extended the cease-fire agreement with Iran. The whipsaw move underscores just how fragile the geopolitical situation remains, even as diplomatic efforts continue.
Sponsored Content
A New Market Theme Is Taking Shape for 2026
Major market shifts rarely start where most people are looking — they begin quietly, in smaller companies that support and enable the bigger themes before anyone's paying attention. Right now, several large-scale innovation themes are re-entering the conversation for 2026, and we've identified the small-caps most likely to move first as that attention spreads.
📊 Pre-Market Movers
Best Buy (BBY) is worth watching after announcing a leadership transition. Jason Bonfig, a 27-year company veteran, will take over as CEO from Corie Barry on October 31. Barry steered the electronics retailer through the pandemic boom and the subsequent normalization, and investors will be looking for continuity rather than dramatic strategy shifts under new management.Amneal Pharmaceuticals (AMRX) is making a bold move, agreeing to acquire Kashiv BioSciences in a cash-and-stock deal valued at up to $1.1 billion. The acquisition expands Amneal's biosimilars portfolio and gives it more scale in the competitive generics market. It's a bet that consolidation can drive margin improvement in a price-pressured industry.
Cboe Global Markets (CBOE) is streamlining its international footprint, selling its Canadian and Australian exchanges to TMX Group for $300 million. The move lets Cboe focus capital and management attention on faster-growing U.S. options and derivatives markets where it has dominant market share. Sometimes addition by subtraction makes sense.
🔍 Today's Watchlist
- Boeing earnings follow-through and 737 Max certification timeline clarity
- Merck's dual offensive: Google AI partnership execution and Inhibrx bidding war
- Oil price stability around $100 as Iran cease-fire extension takes hold
- Treasury yields pushing higher with 10-year now at 4.29%, testing resistance
- Bitcoin climbing back above $78K, up 2.6% as crypto sentiment improves
Sponsored Content
America's National Nightmare Is Coming
The reclusive Oregon forecaster who accurately predicted both the 2008 banking collapse and the post-2020 inflation crisis says a huge event is coming to America this month. He's warning that very soon, life in America is going to take a strange and dangerous turn...
🎯 The Morning Playbook
The setup today favors stock pickers over index chasers. With futures barely budging, the action will be in individual names responding to earnings, deals, and contract wins. Boeing's progress is a reminder that even deeply troubled companies can turn the corner when execution improves. Merck's dual push into AI and biotech shows how Big Pharma is adapting to a world where technology and targeted therapies are reshaping the industry.Keep an eye on oil and rates. If crude can hold below $100, it takes some inflation pressure off the table. But if yields keep climbing, growth stocks could face renewed headwinds. The 10-year is now at 4.29%, up 4 basis points, and that's starting to get uncomfortably close to levels that caused turbulence earlier this year.
Play it measured today. The pre-market mood is cautiously optimistic, but there's not much conviction in these small futures gains. Let the market prove itself in the opening hour before making big bets. Sometimes the best trade is patience.